Document:

Form of STERIS Corp. Nonqualified Stock Option Grant Agreement--Directors

 Exhibit 10.4 
  
 STERIS CORPORATION 
  
 NONQUALIFIED STOCK OPTION AGREEMENT 
  
 This Agreement is made as of [Date of Grant], between STERIS Corporation (“STERIS”) and [Director’s Name], a Director of STERIS
(“Optionee”), to memorialize the grant of a Nonqualified Stock Option by STERIS to Optionee pursuant to the STERIS Corporation 1997 Stock Option Plan (the “Plan”). (Capitalized terms used in this Agreement and not otherwise
defined have the same meanings assigned to them in the Plan.) 
  
 1. Grant of
Option. STERIS hereby grants to Optionee, as of [Date of Grant], an option (the “Option”) to purchase [Number of Shares Granted] STERIS Common Shares, at an exercise price of [Grant Price] per share. The Option is
granted as additional consideration for services to be rendered by Optionee during the Annual Term commencing on the date of the [Current Year] Annual Meeting and continuing through the date of the Annual Meeting of the shareholders of STERIS
to be held in [Following Year]. The Option is subject to all of the terms and conditions of the Plan. 
  
 2. Documents Delivered with Agreement. STERIS has delivered to Optionee, along with two copies of this Agreement, the following documents: (a) a copy of the Plan, (b) a copy of STERIS’s Policy Prohibiting
the Improper Use of Material Non-Public Information (the “Non-Public Information Policy”), and (c) two copies of an acknowledgment form (the “Acknowledgment Form”). By executing this Agreement, Optionee acknowledges receipt of
these documents. 
  
 3. Terms and Conditions of Option. The Option is a
Nonqualified Option and shall not be treated as an Incentive Stock Option. Except as otherwise provided in this Agreement, the Option shall be subject to all of the terms and conditions of the Plan. As a condition to the effectiveness of the Option,
Optionee must return to STERIS signed copies of (a) this Agreement and (b) the Acknowledgment Form. If Optionee violates the terms of this Agreement, the Non-Public Information Policy, or any similar agreement previously entered into (collectively
“Prior Agreements”) any and all options to purchase Common Shares that were granted by STERIS to Optionee (including the Option granted by this Agreement or any Prior Agreements) shall be forfeited, void, and of no further force and
effect. 
  
 4. Term of Option. The Option shall be exercisable not earlier
than [Six Months after Date of Grant] and shall terminate at the close of business on and shall not be exercisable at any time after [Ten Years and One Month from Date of Grant], except as provided in Section 7.3 of the Plan.

  
 5. Exercise of Option. Except as provided in the last sentence of this
Section 5 or in Section 6 below, the option shall be exercisable only by Optionee and only during the continuance of Optionee’s service as a Director or within three months after termination of such service. If Optionee dies while serving as a
Director of STERIS, the Option shall be exercisable for a period of one year after the date of Optionee’s death by Optionee’s executor or administrator or the person or 

  

 
persons to whom Optionee’s rights under the Option are transferred by will or the laws of descent and distribution. 
  
 6. Continued Exercise after Qualifying Retirement. If Optionee retires from service as
a director of STERIS (I) with the consent of or under guidelines approved by the Committee, (II) before [Ten Years and One Month from Date of Grant], (III) after having attained age 55, and (IV) after having served as a director of STERIS for
at least five consecutive years, as defined below (a retirement in such circumstances being a “Qualifying Retirement”), then, so long as Optionee remains in “Good Standing,” as defined below Optionee will be entitled to exercise
vested Options from time to time on any date during the period (the “Extended Exercise Period”) that begins on the date of retirement and ends on the first to occur of (i) [Ten Years and One Month from Date of Grant] (which, as set
forth in Section 6 above, is the scheduled termination date of the Option), and (ii) the fifth anniversary of the date of retirement. 
  
 If, at any time during the Extended Exercise Period, Optionee fails to remain in Good Standing, any and all options then outstanding and held by Optionee (whether granted
under this or any other agreement) shall be forfeited and of no force or effect. For these purposes, in order for Optionee to remain in Good Standing during the Extended Exercise Period, Optionee must not violate either the Policy or any other
STERIS policy and must refrain from acting in a manner detrimental to the interests of STERIS. If, at any time during the Extended Exercise Period, Optionee directly or indirectly materially competes with STERIS, Optionee will be deemed to have
acted in a manner detrimental to the interests of STERIS and will, therefore, be deemed not to be in Good Standing for purposes of this Section 6. 
  
 If Optionee dies during the Extended Exercise Period and while in Good Standing, the Option will thereafter be exercisable to the same extent and at the same times (for
so long and only so long after Optionee’s death) as if Optionee had continued in service as a director of STERIS through the date of Optionee’s death. Unless otherwise determined by the Committee, Optionee will be deemed to have
“served as a director of STERIS for at least five consecutive years” only if Optionee served continuously as a director of STERIS throughout the five year period ending on the Service Termination Date. 
  
 7. Method of Exercise. The Option shall be exercised by delivery of (a) the Exercise
Price payable in accordance with Section 6.4 of the Plan and (b) a written notice to STERIS identifying this Agreement and specifying the number of Common Shares as to which the Option is being exercised. STERIS shall deliver to Optionee
certificates representing the Option shares as soon as administratively feasible following such exercise. 
  
 8. Miscellaneous. Nothing contained in this Agreement shall be understood as conferring on Optionee any right to continue as a Director of STERIS. This Agreement shall inure to the benefit of and be binding
upon its parties and their respective heirs, executors, administrators, successors, and assigns, but the Option shall not be transferable by Optionee otherwise than by will or the laws of descent and distribution. 
  

 2 

 IN WITNESS WHEREOF, STERIS has caused this Agreement to be executed on its behalf by its duly authorized officer, and
Optionee has hereunto set his hand, all as of the day and year first written above. 
  

					
	STERIS Corporation	 	 	 	 Optionee

			
	By: /s/ Mark D. McGinley	 	 	 	  
	 Mark D. McGinley
 Vice President, General Counsel, and
Secretary
	 	 	 	[Director’s Name]

  

 3Form of incentive stock option agreement

 Exhibit 10.115 
  

									
	 	 	 	  	Aeolus Pharmaceuticals, Inc.
	Notice of Grant of Stock Options	 	 	  	 
	and Option Agreement	 	 	  	 ID: 56-1953785
 P.O. Box 14287, 79
T.W. Alexander Dr.
 4401 Research Commons, Suite 200
 Research
Triangle Park, NC 27709-4287

					
	[Optionee Name & address]	 	 	  	 	  	Option Number:	 	  
 __________

	 	 	 	  	 	  	Plan:	 	2004
	 	 	 	  	 	  	ID:	 	__________

  
 Effective [option date], you have been
granted a(n) Incentive Stock Option to buy                      shares of Aeolus Pharmaceuticals, Inc. (the Company) stock at [exercise price]
per share. 
  
 The total option price of the shares granted is
$                    . 
  
 Shares in each period will become fully vested on the date shown. 
  

							
	 Shares

	 	 Vest Type

	 	 Full Vest

	 	 Expiration

  
 By your signature and the
Company’s signature below, you and the Company agree that these options are granted under and governed by the terms and conditions of the Company’s Stock Option Plan as amended and the Option Agreement, all of which are attached and made a
part of this document. 
  

			
	  

	  	  

	Aeolus Pharmaceuticals, Inc.	  	Date
	  

	  	  

	[Optionee Name]	  	Date

 AEOLUS PHARMACEUTICALS, INC. 
  
 1994 STOCK OPTION PLAN 
  
 INCENTIVE STOCK OPTION AGREEMENT 
  
 AEOLUS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) has adopted the 1994 Stock Option Plan, as amended, (the “Plan”), a copy of which
has been provided to Optionee. The Company has granted the Optionee an Incentive Stock Option in accordance with the terms of the Notice of Grant of Stock Options (“Grant Notice”) issued to the Optionee. This Option is subject to the terms
and conditions of the Plan. Capitalized terms used herein and not defined have the same meanings as set forth in the Plan. 
  
 IT IS AGREED as follows: 
  
 1. Grant of Option. The Company hereby grants to the Optionee as of the date of the Grant Notice the right and option to purchase (subject to adjustment pursuant to Section 15 of the Plan) the number of shares
specified in the Grant Notice of its Common Stock, $.01 par value, (“Common Stock”) at an option exercise price per share equal to the exercise price per share specified in the Grant Notice. 
  
 2. Option Period. The option granted hereby shall expire on the tenth anniversary of
the date of the Option grant, subject to earlier termination as provided in the Plan or this Option Agreement. 
  
 3. Exercise of Option. 
  
 A. The Optionee may exercise the Option hereby granted to the extent vested, from and after the dates set forth in the Grant Notice on a cumulative basis. 
  
 B. The Optionee may exercise all or a portion of the Option (to the extent then exercisable) by delivering to the Company a
written notice duly signed by the Optionee stating the number of shares that the Optionee has elected to purchase and accompanied by (i) payment of an amount equal to the full purchase price for the shares to be purchased, or (ii) any other method
of payment provided for in the Plan to which the Committee of the Company’s Board of Directors administering the Plan may consent. Within twenty days after receipt by the Company of such notice and payment, the Company shall issue the shares in
the name of the Optionee and deliver the certificate therefor to the Optionee. No shares shall be issued until full payment therefor has been made, and the Optionee shall have none of the rights of a stockholder with respect to such shares until
they are issued. 
  
 4. Termination. Nothing contained in this Option
Agreement shall confer upon the Optionee any right to remain an employee or consultant of the Company. If the Optionee’s position with the Company as an employee or consultant is terminated for any reason, this Option shall be exercisable only
as to those shares immediately purchasable by Optionee at the date of termination for the remaining term of the option as specified in the Grant Notice. 

 5. Non-Transferability of Option. This Option shall not be transferable, other than by will or by the laws of
descent and distribution, and may be exercised during the Optionee’s lifetime only by the Optionee. 
  
 6. Tax Status. The Option hereby granted is intended to qualify as an incentive stock option within the meaning of Section 422 of the Code. If Optionee ceases to be an employee of the Company, this option will
cease to be an incentive stock option in accordance with the time frame set forth in the Code. 
  
 7. Incorporation of Plan. This Option is subject to, and governed by, all the terms and conditions of the Plan, which are hereby incorporated by reference. The Grant Notice and this Option Agreement, including
the Plan incorporated by reference herein, represents the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings. In the case of any conflict between the terms of
this Agreement and the Plan, the provisions of the Plan shall control. 
  
 8.
Purchase for Investment. To the extent that the Shares underlying this Option are not registered, as a condition to the exercise in whole or in part of the option hereby granted, each written notice of election shall include a representation
by the Optionee that the shares are being purchased for investment and not for distribution or resale. 
  
 9. Notices. Any notice to be given by the Optionee hereunder shall be sent to the Company at its principal executive offices, and any notice from the Company to the Optionee shall be sent to the Optionee at
Optionee’s address set forth in the Grant Notice; all such notices shall be in writing and shall be delivered in person or by registered or certified mail. Either party may change the address to which notices are to be sent by notice in writing
given to the other in accordance with the terms hereof. 
  
 10. Governing
Law. The parties hereto hereby acknowledge and agree that the Option granted hereby is granted in the State of North Carolina and any shares issued upon exercise of the Option will be issued in the State of North Carolina. This Agreement, as
well as the grant of such Option and issuance of such shares, is and shall be governed by and construed in accordance with the laws of the State of North Carolina applicable to the agreements made and to be performed entirely within such State.

  
 11. Signatures. The signatures of the Optionee and the Company on the
Grant Notice indicate both parties’ acceptance to abide by the terms of this Option Agreement and the Plan. 

 PURCHASE FORM 
  
 (To be signed and delivered to 
 Aeolus Pharmaceuticals, Inc. 
 upon exercise of the Option) 
  
 The undersigned, the holder of the foregoing Option, hereby irrevocably elects to exercise
the Stock Option for the purchase of                      shares of Common Stock of Aeolus Pharmaceuticals, Inc. (“Shares”) and
herewith makes payment of $                     ($             per share)
therefor, plus $                 ($ per share) for withholding tax, if any, required in connection with the exercise of the Stock Option, and requests that the
Certificates for the Shares be issued in the name(s) of, and delivered to the address(es) set forth below. 
  

	
	  

	Signature
	
	  

	Print Name

  
 Dated:                , 20     
  

	
	Issue Certificates in
	Following Name:
	
	  

	  

	  

	Address

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]